Status:
TERMINATED
Consumer Assessment of Tobacco Flavor and Odor
Lead Sponsor:
Roswell Park Cancer Institute
Collaborating Sponsors:
National Cancer Institute (NCI)
University of Rochester
Conditions:
Current Vaper
Healthy Subject
Eligibility:
All Genders
21-55 years
Brief Summary
This trial studies consumer assessments of tobacco flavor and odor. This study will compare the ability of expert and consumer panels to identify and characterize flavors, determine threshold detectio...
Detailed Description
PRIMARY OBJECTIVE: I. Develop consumer (untrained) sensory panels to identify and assess characterizing flavors in electronic (e)-liquids. OUTLINE: Non-user panelists smell and user panelists puff ...
Eligibility Criteria
Inclusion
- CONSUMER USER: Current daily vapers of products containing nicotine
- CONSUMER USER: No concurrent use of other tobacco products
- CONSUMER USER: General good health
- CONSUMER USER: No allergies
- CONSUMER USER: No self-reported taste or smell deficits
- CONSUMER USER: Not pregnant or lactating
- CONSUMER USER: No medications known to interfere with taste/smell
- CONSUMER USER: Passing scores on the Brief Smell Identification Test (B-SIT), phenylthiocarbamine (PTC) and 6-n-propylthiouracil (PROP) smell and taste tests
- CONSUMER USER: No positive diagnosis of COVID-19 within 30 days
- CONSUMER NONUSER: No use of tobacco or nicotine products in the last year
- CONSUMER NONUSER: General good health
- CONSUMER NONUSER: No allergies
- CONSUMER NONUSER: No self-reported taste or smell deficits
- CONSUMER NONUSER: Not pregnant or lactating
- CONSUMER NONUSER: No medications known to interfere with taste/smell
- CONSUMER NONUSER: Passing scores on the Brief Smell Identification Test (B-SIT), phenylthiocarbamine (PTC) and 6-n-propylthiouracil (PROP) smell and taste tests
- CONSUMER NONUSER: No positive diagnosis of COVID-19 within 30 days
Exclusion
- CONSUMER USER: Outside age range
- CONSUMER USER: Not current daily vapers
- CONSUMER USER: Concurrent use of other tobacco products
- CONSUMER USER: Fair or poor general health
- CONSUMER USER: Allergies
- CONSUMER USER: Self-reported taste or smell deficits
- CONSUMER USER: Pregnant or lactating
- CONSUMER USER: Medications known to interfere with taste/smell
- CONSUMER USER: Failing scores on the Brief Smell Identification Test (B-SIT), phenylthiocarbamine (PTC) and 6-n-propylthiouracil (PROP) smell and taste tests
- CONSUMER USER: Positive diagnosis of COVID-19 within 30 days
- CONSUMER NONUSER: Outside age range
- CONSUMER NONUSER: Use of tobacco or nicotine products in the last year
- CONSUMER NONUSER: Fair or poor general health
- CONSUMER NONUSER: Allergies
- CONSUMER NONUSER: Self-reported taste or smell deficits
- CONSUMER NONUSER: Pregnant or lactating
- CONSUMER NONUSER: Medications known to interfere with taste/smell
- CONSUMER NONUSER: Failing scores on the Brief Smell Identification Test (B-SIT), phenylthiocarbamine (PTC) and 6-n-propylthiouracil (PROP) smell and taste tests
- CONSUMER NONUSER: Positive diagnosis of COVID-19 within 30 days
Key Trial Info
Start Date :
April 3 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 9 2025
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT04358315
Start Date
April 3 2023
End Date
December 9 2025
Last Update
January 6 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Roswell Park Cancer Institute
Buffalo, New York, United States, 14263